| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Human Motor Control Section (V.V.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; and Department of Psychiatry (V.V., M.Z., M.D.) and Division of Neurology (K.H., S.D.-C., S.F., A.E.L., J.M.), Toronto Western Hospital, Toronto, Canada.
Address correspondence and reprint requests to Dr. Valerie Voon, Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 10, Room 5S213, 10 Center Drive, Bethesda, MD 20892-1428; e-mail: voonv{at}ninds.nih.gov
The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.
Disclosure: The authors report no conflicts of interest.
Received December 9, 2005. Accepted in final form February 17, 2006.
This article has been cited by other articles:
|
|
 |
|
  K Wu, M Politis, and P Piccini Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management Postgrad. Med. J., November 1, 2009; 85(1009): 590 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Olanow, M. B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology, May 26, 2009; 72(21_Supplement_4): S1 - S136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. L. Steeves, J. Miyasaki, M. Zurowski, A. E. Lang, G. Pellecchia, T. Van Eimeren, P. Rusjan, S. Houle, and A. P. Strafella Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study Brain, May 1, 2009; 132(5): 1376 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bostwick, K. A. Hecksel, S. R. Stevens, J. H. Bower, and J. E. Ahlskog Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease Mayo Clin. Proc., April 1, 2009; 84(4): 310 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A H Evans, A D Lawrence, and A J Lees Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 267 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Lang When and how should treatment be started in Parkinson disease? Neurology, February 17, 2009; 72(7_Supplement_2): S39 - S43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Floresco, J. R. St. Onge, S. Ghods-Sharifi, and C. A. Winstanley Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making Cogn Affect Behav Neurosci, December 1, 2008; 8(4): 375 - 389. [Abstract] [PDF]
|
|
|
|
 |
|
 C. A. Davie A review of Parkinson's disease Br. Med. Bull., June 1, 2008; 86(1): 109 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Voon and S. H. Fox Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease Arch Neurol, August 1, 2007; 64(8): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H Wong and M. J Steiger Pathological gambling in Parkinson's disease BMJ, April 21, 2007; 334(7598): 810 - 811. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Dewey Jr, S. C. Reimold, and P. E. O'Suilleabhain Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonists in Parkinson Disease Arch Neurol, March 1, 2007; 64(3): 377 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Voon, T. Thomsen, J. M. Miyasaki, M. de Souza, A. Shafro, S. H. Fox, S. Duff-Canning, A. E. Lang, and M. Zurowski Factors Associated With Dopaminergic Drug-Related Pathological Gambling in Parkinson Disease Arch Neurol, February 1, 2007; 64(2): 212 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Voon, K. Hassan, M. Zurowski, M. de Souza, T. Thomsen, S. Fox, A. E. Lang, and J. Miyasaki Prevalence of repetitive and reward-seeking behaviors in Parkinson disease Neurology, October 10, 2006; 67(7): 1254 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Fox, N. P. Visanji, T. H. Johnston, J. Gomez-Ramirez, V. Voon, and J. M. Brotchie Dopamine Receptor Agonists and Levodopa and Inducing Psychosis-Like Behavior in the MPTP Primate Model of Parkinson Disease. Arch Neurol, September 1, 2006; 63(9): 1343 - 1344. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
